This guide covers the current legal position, what changed, and what you need to document to protect your patients and your practice.
What counts as a POM in aesthetic practice
Botulinum toxin, whether Botox, Bocouture, or Azzalure, is a prescription-only medicine under UK law. A prescription from an authorised prescriber must exist before anyone sells, supplies, or administers it.
Dermal fillers are not POMs. The MHRA classified them as medical devices in 2020. But hyaluronidase, which you need for managing vascular occlusion emergencies, is a POM. A prescriber has to supply your emergency kit regardless of whether you administer fillers or toxin.
Other products used in aesthetic practice that are POMs include certain topical anaesthetics and some skinbooster formulations. If you are unsure about a product, check its summary of product characteristics.
Who can legally prescribe?
Four types of practitioners can prescribe botulinum toxin in the UK: a GMC-registered doctor, a GDC-registered dentist within their scope of practice, an NMC-registered nurse with the V300 independent prescriber qualification, or a GPhC-registered pharmacist independent prescriber.
Supplementary prescribers can prescribe within a clinical management plan, with a doctor as the responsible independent prescriber. Nurses without V300, aestheticians, and beauticians cannot prescribe botulinum toxin under any circumstances.
Non-prescribing practitioners can legally administer botulinum toxin against a valid prescription issued by an authorised prescriber following a compliant consultation. Administering and prescribing are distinct acts with distinct legal responsibilities.
What changed in June 2025?
From 1 June 2025, NMC rules require nurse and midwife prescribers to consult patients face to face before prescribing botulinum toxin or aesthetic emergency kit items. The NMC position is direct: a nurse or midwife cannot prescribe these medicines unless they have personally carried out an in-person consultation and full clinical assessment of the patient.
Remote prescribing for these treatments is now non-compliant. If your clinic used a prescribing nurse conducting remote consultations to issue prescriptions for your patients, that arrangement needs to change. The prescription, the consultation, and the prescriber must all be in the same room as the patient.
The prescriber partnership model
Most non-prescribing practitioners work with an independent prescriber under a documented partnership arrangement. This is legal. The documentation requirements around it are specific.
Your prescriber must meet the patient face to face, conduct a full clinical assessment, and issue the prescription personally. You administer the treatment against that prescription. You cannot amend the prescription, substitute a different product, or administer a different dose without a new prescriber assessment.
Document every step of the patient journey:
The prescriber's consultation findings and clinical decision
The prescription, including product, dose, sites, and prescriber details and registration number
Your treatment notes, including dose actually administered and sites treated
Any complications and how you managed them
Batch numbers and product details for every vial used
All of this needs to live in one place. A prescriber recording their consultation in one system and a practitioner writing treatment notes in a different one, or on paper, creates gaps that are indefensible if a complaint is investigated.
Managing POM stock
Store botulinum toxin at the temperature specified in its product summary. Record the batch number and expiry date for every unit you receive. Track which patients received treatment from each batch and on which date. Document disposal of unused product.
Batch tracking exists for patient safety. If a product is recalled, you need to identify every patient who received a treatment from an affected batch and contact them quickly. A clinic that cannot produce that list is in a legally and clinically indefensible position.
Emergency medications
Every clinic administering botulinum toxin or hyaluronic acid fillers needs emergency medications available during treatment sessions. The minimum is adrenaline for anaphylaxis. Clinics administering HA fillers need hyaluronidase for vascular occlusion management.
These medications are POMs. Your prescriber has to supply them for clinic stock. Check expiry dates on a fixed schedule, document the check, and make sure every practitioner who treats patients in your clinic knows where the kit is and can use it competently.
Expired adrenaline in a drawer is a clinical and legal liability. Treat emergency kit maintenance as a clinical task, not an admin one.
What your software needs to handle
The documentation requirements for POM prescribing are too detailed to manage reliably on paper. A spreadsheet does not link a patient's treatment notes to their prescription. Paper records cannot automatically capture the prescriber's name, registration number, and qualification alongside the clinical assessment.
Your clinic management software needs to link each treatment record to the authorising prescription and prescriber, record batch numbers against each patient's notes, flag products approaching expiry, and produce a complete patient audit trail that any practitioner can retrieve in under five minutes.
General salon booking platforms do not have these workflows. If your software has no concept of a prescription or a prescriber, your documentation does not meet the standard that regulators and insurers now expect, regardless of how carefully your team fills things in manually.
The short version
Botulinum toxin requires a prescription after a face-to-face consultation. Nurse prescribers cannot prescribe remotely for these treatments. Non-prescribers can administer but cannot prescribe. Document every step from prescriber consultation to treatment completion. Record batch numbers. Keep emergency medications in date and your team trained to use them.
The regulatory environment now treats this level of documentation as standard. The incoming licensing framework will give inspectors formal tools to check for it.
Explore how Calyx handles POM workflows, prescriber authorisation, and batch tracking on the platform page, or book a demo with the team.
